Rocket Pharmaceuticals, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, Suite 7530, New York, NY

Insiders trading volume in the past year

Rocket Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Roderick Wong Director, 10%+ Owner $143M Jun 18, 2025
Rtw Investments, Lp Director, Other*, 10%+ Owner $101M Sep 19, 2025
Gotham Makker Director $8.15M Jun 18, 2025
Gaurav Shah CEO, Director $7.41M -$254K -3.31% Aug 18, 2025
Kinnari Patel President, Head of R&D and Chief Operating Officer $6.42M -$39.2K -0.61% May 20, 2025
Christopher James Stevens Chief Operating Officer $3.2M Aug 4, 2025
Aaron Ondrey Chief Financial Officer $3.03M -$39.6K -1.29% Jul 3, 2025
Martin Wilson General Counsel $2.98M -$101K -3.27% Sep 8, 2025
Jonathan David Schwartz Chief Medical & Gene Therapy Officer $2.81M -$166K -5.59% Sep 8, 2025
Mark Andrew White General Manager, Commercial Affairs $1.61M -$51.2K -3.09% Oct 31, 2024
Carlos Garcia-Parada Chief Financial Officer $1.14M Feb 14, 2022
David P. Southwell Director $1.14M Jun 18, 2025
John Militello Vice President of Finance, Treasurer, Principal Accounting Officer $771K -$106K -12.1% Sep 8, 2025
Mikael Dolsten Director $693K Jun 18, 2025
Piratip Pratumsuwan Director $573K Jun 18, 2025
Pedro P. Granadillo Director $430K Jun 18, 2025
Keith Woods Director $360K Jun 13, 2024
Fady Ibraham Malik Director $236K Jun 18, 2025
Carsten Boess Director $236K Jun 18, 2025
Peter Fong Director $175K Sep 24, 2025
Elisabeth Bjork Director $146K +$34.1K +30.6% Aug 27, 2025
Naveen Yalamanchi Director $104K Jun 13, 2024
Sarbani Chaudhuri Chief Commercial & Medical Affairs Officer Exhibit 24: Power of Attorney Apr 7, 2025
Syed Ali-aamir Rizvi Chief Medical Officer. Exhibit 24: Power of Attorney Sep 15, 2025

Recent Insider Transactions by Companies or Individuals for Rocket Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.